[Study reports that RAPADILINO patients identified as carriers of the c.1390+2delT mutation (p.Ala420 _ Ala463del) are at increased risk to develop lymphoma or osteosarcoma (6 out of 15 patients).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE